Skip to main content

Table 4 Radio-chemotherapy related adverse events

From: Chemo-radiotherapy plus durvalumab for loco-regional relapse of resected NSCLC

  Frequency %
Esophagitis 14 58.3
 G1 7 29.2
 G2 5 20.8
 G3 2 8.3
Pneumonitis G1 1 4.2
Hematological toxicity 5 20.8
 G1 3 12.5
 G2 2 8.3